id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3287-0005,FDA,FDA-2019-E-3287,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-12-29T05:00:00Z,2023,12,2023-12-29T05:00:00Z,,2023-12-29T14:14:00Z,,0,0,0900006486365c60
FDA-2019-E-3287-0004,FDA,FDA-2019-E-3287,Determination of Regulatory Review Period for Purposes of Patent Extension; Copiktra,Notice,Determinations,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,2024-02-21T04:59:59Z,2023-12-22T15:41:59Z,2023-28244,0,0,090000648635121b